ZATTONI, LORENZO
ZATTONI, LORENZO
Dipartimento di Oncologia ed Emato-Oncologia
HER2 Testing in Breast and Gastric Cancer with CDH1 Germline Mutations
2023 M. Ivanova, E. Sajjadi, L. Zattoni, N. Fusco
Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials
2022 M. Invernizzi, L. Lippi, A. Folli, A. Turco, L. Zattoni, A. Maconi, A. de Sire, N. Fusco
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer
2022 S. Morganti, A. Marra, K. Venetis, E. Sajjadi, L. Ascione, C. Corti, P. Zagami, M. Ivanova, L. Zattoni, G. Curigliano, N. Fusco, C. Criscitiello
Axillary Web Syndrome in Breast Cancer Women: What Is the Optimal Rehabilitation Strategy after Surgery? A Systematic Review
2022 L. Lippi, A. De Sire, L. Losco, K. Mezian, A. Folli, M. Ivanova, L. Zattoni, S. Moalli, A. Ammendolia, C. Alfano, N. Fusco, M. Invernizzi
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
2022 C. Corti, K. Venetis, E. Sajjadi, L. Zattoni, G. Curigliano, N. Fusco
Standard operating procedures for biobank in oncology
2022 G. Bonizzi, L. Zattoni, M. Capra, C. Cassi, G. Taliento, M. Ivanova, E. Guerini-Rocco, M. Fumagalli, M. Monturano, A. Albini, G. Viale, R. Orecchia, N. Fusco